Is amoxicillin‑clavulanate (Augmentin) appropriate for treating a skin abscess?

Augmentin is NOT appropriate as first-line treatment for uncomplicated skin abscesses

For simple skin abscesses, incision and drainage alone is the definitive treatment—antibiotics including Augmentin are unnecessary unless specific systemic criteria are met. 1

When Antibiotics Are NOT Needed

The 2014 IDSA guidelines are explicit: if the patient has minimal systemic signs of infection (temperature <38.5°C, WBC <12,000 cells/µL, pulse <100 beats/minute) and erythema <5 cm, antibiotics are unnecessary after incision and drainage. 1 Multiple studies demonstrate little to no benefit when antibiotics are added to adequate drainage for simple abscesses 1.

When Antibiotics ARE Indicated

Antibiotics should be added to incision and drainage when the patient meets SIRS criteria (Systemic Inflammatory Response Syndrome):

• Temperature >38°C or <36°C
• Heart rate >90 beats/minute
• Respiratory rate >24 breaths/minute
• WBC >12,000 or <4,000 cells/µL

OR when there is:

• Erythema extending >5 cm beyond wound margins 1
• Markedly impaired host defenses 1

Why Augmentin is NOT the Right Choice

When antibiotics are indicated for skin abscesses, the primary concern is MRSA coverage—and Augmentin does NOT cover MRSA. 1 The IDSA guidelines specifically recommend antibiotics active against MRSA (such as trimethoprim-sulfamethoxazole, doxycycline, or clindamycin) for patients with abscesses requiring antibiotic therapy 1.

Augmentin's Limited Role

Augmentin (amoxicillin-clavulanate) is FDA-approved for pediatric recurrent otitis media 2, not skin abscesses. While older studies from the 1980s-1990s showed Augmentin could treat some skin infections 3, 4, these predate the MRSA epidemic. In the current era where community-acquired MRSA is a dominant pathogen in skin abscesses, Augmentin's spectrum is inadequate.

The only scenario where Augmentin might be considered is for polymicrobial infections in specific anatomic locations (axilla, perineum, post-surgical wounds involving intestinal/genital tracts) where mixed aerobic-anaerobic flora is expected 1—but even then, it should be combined with MRSA coverage.

Clinical Algorithm for Skin Abscess Management

1. Perform incision and drainage (definitive treatment) 1
2. Assess for systemic involvement:
   • Check vital signs and WBC
   • Measure erythema extent
3. If minimal systemic signs and erythema <5 cm: Stop—no antibiotics needed 1
4. If SIRS criteria present or erythema >5 cm: Add MRSA-active antibiotic (TMP-SMX, doxycycline, or clindamycin) 1
5. Culture the abscess contents to guide therapy if needed 1

Critical Pitfall to Avoid

Do not prescribe Augmentin reflexively for skin abscesses simply because it's a "broad-spectrum" antibiotic. This promotes resistance, adds unnecessary cost and side effects, and fails to cover the most likely pathogen (MRSA). The evidence is clear: drainage is definitive; antibiotics are adjunctive only when systemic criteria are met; and when needed, MRSA coverage is essential.